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Abstract 
There is limited evidence on the efficacy of awake prone posi-
tioning (PP) in non-ventilated patients with COVID-19 who have
hypoxemia. We, therefore, aim to describe our experience with the
use of early proning in awake, non-intubated patients with con-
firmed COVID-19. In our retrospective observational study, 23
patients with confirmed positive PCR test results for Severe Acute
respiratory Syndrome Coronavirus-2 (SARS-CoV-2) and hypox-
emia that required oxygen therapy with or without non-invasive
ventilation were treated with PP. Patients were classified into
mild, moderate and severe COVID-19 disease. There were no tar-
geted number of hours for proning per day and patients were kept
in prone position according to their tolerance. The primary out-
come measure was the avoidance of intubation and secondary out-
comes were in-hospital mortality, length of hospital stays and
complications related to PP. The mean (standard deviation) age of
our cohort was 54.5 (11.7) years, and the majority were males
(21/23, 91.3%). Sixty-one per cent (14/23) of the patients were
suffering from severe disease and 82.6% (19/23) had bilateral lung
involvement with interstitial infiltrates. Majority of the patients
were prone positioned for a median of 6 days (IQR 4 – 8). Only
one patient required transfer to ICU for mechanical ventilation
and subsequently died due to severe ARDS. All 22 patients
showed progressive improvement in oxygen requirement and PF
ratio, mostly after 3-5 days of proning. The mean length of hospi-
tal stay was 12 days. All patients, except one, were discharged in
stable conditions, on room air or on a minimal oxygen require-
ment of 1-2 liters. No major complication of PP was recorded.
Awake prone positioning is a valuable and safe therapeutic adjunct
that can be applied in patients with moderate-to-severe COVID-
19. It can also be included in the home-based management proto-
cols of COVID-19 to improve patient outcomes and mitigate the
burden on health care facilities.
Introduction
The Coronavirus Disease 2019 (COVID-19) crisis, a global
pandemic caused by Severe Acute Respiratory Syndrome
Coronavirus-2 (SARS-CoV-2) continues to spiral at an alarming
rate since its initial detection in Wuhan, China in December 2019.
Hypoxemic respiratory failure and acute respiratory distress syn-
drome (ARDS), leading to mechanical ventilation are common
manifestations of this disease process and are associated with a
higher morbidity and mortality rate [1]. The fragile and under-
resourced health care systems of developing countries are facing
severe limitations in managing patients during the current pan-
demic, especially given their constrained capacity and resource
shortages [2]. While there is an urgent need of non-invasive and
invasive ventilators in low-to-middle-income countries (LMIC),
there is also a dire need for cost-effective, scalable modalities that
can help in managing acute hypoxemia which, if left untreated,
can rapidly progress to ARDS and respiratory failure [3,4].
Prone position ventilation or proning, first proposed in 1974,
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is an authenticated technique used in the treatment of patients with
ARDS and has been shown to  significantly improve hypoxemia
[5,6]. Patients with ARDS requiring invasive ventilation are placed
in a prone position with their face down and specific prone venti-
lation protocols have been established to safely perform this
manoeuvre [7,8]. Prone positioning (PP) improves gas exchange
via several mechanisms that improve the ventilation perfusion
ratio. It involves the more equal distribution of ventilation with the
redistribution of perfusion, recruitment of dorsal alveoli and
increased lung volume [9-11]. It may also promote enhanced clear-
ance of secretions from the lungs which improves the ventilation-
perfusion ratio [10]. The other possible mechanism would be an
increased end-expiratory transpulmonary pressure and a more uni-
form distribution of pleural pressure [12,13].
Earlier studies have established that oxygenation is consider-
ably better with prone position ventilation as compared to the
supine position, but data related to its effect on mortality has not
been very convincing [14-16]. The prone positioning in severe
acute respiratory distress syndrome (PROSEVA) trial demonstrat-
ed a significant reduction of 28 days and 90 days of mortality in
patients with severe ARDS who received PP [17]. The results of
this trial were later supported by succeeding studies including
meta-analysis and therefore, PP is now considered as an effective
adjunctive therapeutic strategy in ARDS. It decreases mortality
especially in patients with severely impaired oxygenation, when
initiated early and for a long duration [11,18-21]. Prone position-
ing is also considered to be effective in COVID-19 related ARDS
and has been recommended by surviving sepsis campaign COVID-
19 management guidelines for critically ill adults [22-24].
The efficacy of PP in awake, spontaneously breathing, non-
intubated patients is also documented in literature, but data is lim-
ited. Awake prone position in patients with acute hypoxemia has
demonstrated beneficial effects including avoidance of intubation
[25-27]. A retrospective study by Scaravilli et al. showed that
awake proning of non-intubated patients with hypoxemia resulted
in a marked improvement in oxygenation and was not associated
with serious complications [28].
The role of PP in awake, non-intubated patients with COVID-
19 is also an area inadequately explored. In the current crisis,
where the number of patients with COVID-19 are increasing expo-
nentially with each passing day and health care supplies are run-
ning low, awake proning might be a promising, inexpensive and
feasible treatment option for patients with moderate to severe
ARDS in LMIC. 
In this study, we sought to describe our experience with the use
of early proning in awake, non-intubated patients with confirmed
COVID-19. 
Materials and Methods
This single center, retrospective observational study was con-
ducted at Aga Khan University Hospital (AKUH), Karachi,
Pakistan between 1st and 31st May 2020. Established in 1985,
AKUH is one of the largest tertiary care university hospitals of
Pakistan (740 bedded). It provides a broad range of secondary and
tertiary care (both adults and pediatric patients) and caters to a
variety of patients referred from all over Pakistan. It also provides
both undergraduate and postgraduate training in multiple subspe-
cialties. The nurses-to-patient ratio is 1:6 for ward-beds and 1:4 for
high dependency unit overall in the hospital. The internal medicine
department admission census is usually between 100 and 170
patients per month. As it is a training institute, there are 71 post
graduate trainees to take care of the patients under the supervision
of faculty. The physician to patient ratio is between 1:4. There are
three respiratory therapists in medicine department who are
assigned to take care of patients in high dependency unit. During
the COVID-19 pandemic, a part of the hospital has been converted
into a designated COVID-19 treatment facility to provide care to
critical and non-critical patients. Our hospital has gradually
increased its bed capacity in the COVID-19 unit over the period of
4-5 months (beginning from March 2020) where more special care
and ICU beds were added after necessary modification like con-
struction of negative pressure rooms. 
In our study, we included all patients (18 years or above) who
were admitted with moderate to severe COVID-19 and received
PP early on after admission as part of their treatment strategy.
Patients who received PP with invasive mechanical ventilation
were excluded. Moreover, patients with mild COVID-19 or with
incomplete data or those who received proning for 24 hours or less
were also excluded from our study.
COVID-19 was diagnosed by a nasopharyngeal or oropharyn-
geal swab for SARS-CoV-2 using real-time reverse transcription-
polymerase chain reaction (RT-PCR). The severity of disease was
graded according to the National guidelines of management of
COVID-19 established by the Ministry of Health, Pakistan.
According to the guidelines, patients were classified to have mild
disease when they had a normal chest X-ray (CXR), stable hemo-
dynamic parameters and maintained oxygen saturation of ≥94% on
room air. On the other hand, patients with hypoxemia (oxygen sat-
uration <94% but >90%) and chest CXR with infiltrates involving
<50% of lung fields were classified into the moderate disease cat-
egory. Patients were said to have severe disease if their oxygen sat-
uration was <90% on room air and CXR showed infiltrates involv-
ing >50% of lung fields.
A team of physicians, comprising of an internist, an infectious
diseases specialist and an intensivist took care of patients with
COVID-19. The protocol for awake proning was adopted from
previously published studies on awake proning [25]. The decision
to initiate proning was based on the primary physician’s discretion.
Patients were placed in prone position with the help of trained
nursing staff and a respiratory therapist. There was no pre-fixed
targeted number of hours for proning. The frequency of PP and
duration of each session of proning was based on patient’s comfort
level and physician’s discretion. The patients were monitored by
bedside nurses for their comfort and tolerance of PP. Patients were
also counseled about the technique, benefits and complications of
awake proning. Along with demographic data, clinical features and
CXR findings, sequential organ failure assessment (SOFA) score
and PaO2/FiO2 (PF) ratio were recorded before the initiation of the
prone position. Daily FiO2, PF ratio and the number of hours of
proning were recorded for each patient. The primary outcome was
the avoidance of intubation and secondary outcomes were in-hos-
pital mortality and the length of hospital stay. The study was
approved by the Ethical Review Committee (ERC) of the AKUH. 
Statistical analysis
Descriptive analysis was performed; results were reported as
numbers with percentages for categorical variables. Continuous
variables with normal and non-normal distributions were reported
as mean [standard deviation (SD)] and median [interquartile range
(IQR)], respectively. Comparison of baseline and discharge was









done using paired sample t-test. Median values of PF ratio among
NIV vs non-NIV group were compared by Mann-Whitney U test.
All P-value were two sided and <0.05 was considered as statisti-
cally significant. SPSS 19.0 (SPSS Inc., Chicago, IL, USA) was
used for data analysis.
Results
A total of 200 patients were admitted with the diagnosis of
COVID-19 during May 2020. Twenty patients (10%) were admitted
in ICU and required mechanical ventilation, 120 (60%) in general
wards and 60 (30%) in special care unit. Out of 60 patients admitted
in special care unit, 23 met the eligibility criteria and were included
in our study. The mean (sd) age was 54.5 (11.7) years ranging from
31 to 78 years. The majority of our patients were males (21/23,
91.3%) and the most common comorbid conditions were hyperten-
sion and diabetes mellitus. Most of the patients were admitted in the
special care unit directly from the emergency department and 14
patients (60.9%) required non-invasive ventilation (NIV) at the time
of admission. The most common presenting symptoms were fever
(21/23, 91.3%), cough (19/23, 82.6%) followed by shortness of
breath (16/23, 69.6%) and myalgia (7/23, 30.4%). The median num-
ber of days from onset of symptoms to hospitalization was 5 (4-10)
days. Moreover, in our cohort, the majority of patients (60.9%,
14/23) were suffering from severe disease and 82.6% (19/23) had
bilateral lungs involvement with interstitial infiltrates (21/23,
91.3%). All patients received COVID-19 related standard medical
treatment according to National guidelines with careful evaluation
of contraindications to any particular drug (Table 1).
The median SOFA score on the first day before the start of pron-
ing was 3 (3-4) while the median duration between admission and
initiation of PP was 1 (1-2) day. Most patients were prone positioned
for a median of 6 (4-8) days. The minimum number of hours of
awake PP tolerated by any patient was 2.5 and maximum number of
hours was 16 per day. Only one patient required transfer to ICU for
mechanical ventilation and subsequently died due to severe ARDS.
The rest of the 22 patients showed progressive improvement in oxy-
gen requirement and PF ratio but responses were variable owing to
a difference in the severity of illness amongst patients at the outset.
The majority of patients showed improvement in PF ratio after 3-5
days of proning and were successfully tapered off from NIV. The
improvement in PF ratio before and at the end of prone positioning
was observed in patients with both moderate (P=0.008) and severe
disease (P<0.001) (Table 2).
In subgroup analysis, patients who were treated with a combi-
nation of NIV, oxygen therapy and PP were compared with patients
who were treated with PP and oxygen alone, without the use of
NIV. We found no evidence of statistically significant improve-
ment in PF ratio between the two groups, except on day 1 of PP
(P=0.03) (Table 3).
All patients tolerated the PP well except for some mild discom-
fort experienced by most patients. No complication related to PP
like facial edema, vomiting, aspiration, intolerance to prone
manoeuvre, skin lesion, displacement of venous access, hypoten-
sion or arrhythmia was observed in any patient.
The median length of hospital stay was 10 (5-35) days while
the median length of special care stay was of 6 (4-8) days. After
shifting out of special care units, patients spent a median of 4 (3-
6) days in the ward before being discharged home. All patients
except one were discharged in stable condition, on room air or on
a minimal oxygen requirement of 1-2 liters.
Discussion
The mortality with COVID-19 is very high in certain parts of
the world, and most patients suffer from hypoxic respiratory fail-
ure and ARDS leading to requirement of non-invasive as well as
invasive ventilation [29-31]. 
PP is being recognized as an effective adjunctive therapy with
invasive ventilation in patients with COVID-19 with severe ARDS
[32-34]. However, the role of awake PP is not very well defined in
non-ventilated patients with COVID-19. Pre COVID-19, the evi-
dence on the use of PP in awake, non-intubated hypoxic patients
was limited yet encouraging. Although published in the form of
small case series with diverse protocol and different patient popu-
lation, it has revealed promising results as evidenced by improved
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Table 1. Baseline characteristics of study population (n=23).
                                                                                      n (%)
Age, years                                                                                         54.5 (11.7)
Sex                                                                                                               
Male                                                                                                  21 (91.3)
Female                                                                                               2 (8.7)
BMI; mean (SD)                                                                              27.5 (3.3)
Medical conditions
Diabetes mellitus                                                                           6 (26.1)
Hypertension                                                                                  10 (43.5)
Ischemic heart disease                                                                 1 (4.3)
Chronic kidney disease                                                                  1 (4.3)
Chronic obstructive pulmonary disease                                    1 (4.3)
Malignancy                                                                                        1 (4.3)
Immunocompromised state                                                         1 (4.3)
Smoker                                                                                                 2 (8.7)
Symptoms
Fever                                                                                                21 (91.3)
Cough                                                                                               19 (82.6)
Myalgia                                                                                              7 (30.4)
Runny nose                                                                                       1 (4.3)
Sore throat                                                                                       5 (21.7)
Dyspnea                                                                                           16 (69.6)
Nausea                                                                                               2 (8.7)
Vomiting                                                                                             1 (4.3)
Abdominal pain                                                                                1 (4.3)
Diarrhea                                                                                            1 (4.3)
Headache                                                                                          2 (8.7)
Chest tightness                                                                                1 (4.3)
Chills                                                                                                 6 (26.1)
Severity of disease
Moderate                                                                                          9 (39.1)
Severe                                                                                              14 (60.9)
Chest X-ray finding
Unilateral infiltrates                                                                      4 (17.4)
Bilateral infiltrates                                                                        19 (82.6)
Consolidation                                                                                  5 (21.7)
Interstitial infiltrates                                                                    21 (91.3)
Medication
Systemic steroids                                                                          21 (91.3)
Hydroxycholoroquine                                                                   16 (69.6)
Azithromycin                                                                                    9 (39.1)
Tocilizumab                                                                                     13 (56.5)
Plasma                                                                                                2 (8.7)
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hypoxemia, well tolerability by patients and less or no complica-
tions [35]. The proposed mechanisms of improvement in oxygena-
tion by prone position are multifactorial. PP has been witnessed to
facilitate the recruitment of alveoli in dorsal lung regions, increase
tidal and end-expiratory lung volumes, decrease alveolar shunting
as well as improve ventilation-perfusion (V/Q) ratio via a more
homogenous distribution of ventilation [17,18,36]. 
Awake proning was initially included in the management of
patients with COVID-19 in China, the country where the pandemic
started. A study from China reported that the employment of this
technique resulted in improved mortality and prevented intubation
in most patients [37]. This was followed by several small case
series reported from other parts of the world which showed the
positive effect of early awake proning in management of  patients
with COVID-19 in terms of clinical improvement and avoidance
of intubation [38,39]. Few studies also reported that patients only
experienced a transient improvement in oxygenation as oxygen
saturation levels returned to the baseline after supination [40,41].
None of the patient in moderate COVID-19 disease group in our
study developed severe disease. PP might have contributed to
improving oxygen requirement of patients with COVID-19; how-
ever, this needs further validation in future research.    
No adverse events occurred in our cohort and PP emerged as a
safe treatment strategy. Previous works also support the fact that it
is not associated with an increased incidence of complications in
most of the cases [41,42]. In the current crisis, many patients with
COVID-19 are being managed at home with oxygen therapy due
to limited capacity of health care facilities, especially in resource-
poor countries. Our results support the fact that patients and their
families can easily be educated to initiate early awake proning at
home along with close monitoring of oxygen saturation. It may
prove to be an excellent adjunctive therapeutic strategy that
requires minimal resources and can be included in the management
protocol of home-based therapy of patients with COVID-19 in
early hypoxemic stage of illness. However, our study has several
limitations. This is a retrospective single centre study with a small
sample size and no control group. Moreover, we could not elicit
the minimum duration of prone position required to attain a signif-
icant clinical improvement as there were no pre-fixed targeted
hours per day for patients to remain in the prone position. Further
multicentre studies with a larger sample size and pre-defined
awake proning protocol as well as control groups, preferably ran-
domized control trials are required to validate and generalize our
results or draw any definitive conclusions.
Conclusions
As there is no effective therapy available for COVID-19 to
date, clinicians are in a constant struggle to improve supportive
care. Awake PP might prove to be an effective adjunct therapeutic
option that can be applied in patients with moderate to severe
COVID-19. It is a safe and cost-effective measure that has attained
widespread popularity amongst most physicians due to its ease of
application and encouraging results. It can also be initiated at home
as part of management of patients with less severe hypoxemia who
cannot be admitted in hospitals, thus decreasing the load on health
care facilities. However, further studies with larger sample size and
control groups are needed to further validate our findings. 
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